Myelophthisic Anemia

Anemia characterized by appearance of immature myeloid and nucleated erythrocytes in the peripheral blood, resulting from infiltration of the bone marrow by foreign or abnormal tissue.

Also Known As:

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Carcinoma (Carcinomatosis)
2.	Stomach Neoplasms (Stomach Cancer)
3.	Polycythemia Vera
4.	Neoplasm Metastasis (Metastasis)
5.	Hemolytic Anemia

Experts

1.	Blackstein, Martin: 1 article (01/2004)
2.	Rabah, Rola: 1 article (01/2004)
3.	Riddell, Robert H: 1 article (01/2004)
4.	Wang, Chen: 1 article (01/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Myelophthisic Anemia:

1.	ErythropoietinFDA Link 03/01/1976 - "Diminished bone marrow responsiveness to erythropoietin in myelophthisic anemia."
2.	Diethylstilbestrol (Stilbestrol)FDA Link 05/01/1948 - "Myelophthisic anemia the presenting manifestation of prostatic carcinoma with skeletal metastases; the effect of castration and stilbestrol."
3.	Dacarbazine (DIC)FDA LinkGeneric 02/01/1985 - "Leukoerythroblastic anemia, microangiopathic hemolytic anemia and DIC were found more frequently in the gastric cancers than in the others. "

Therapies and Procedures

1.	Castration 11/01/1947 - "The effect of castration and di-ethyl stilboestrol in a patient with myelophthisic anemia secondary to carcinoma of the prostate." 05/01/1948 - "Myelophthisic anemia the presenting manifestation of prostatic carcinoma with skeletal metastases; the effect of castration and stilbestrol."
2.	X-Ray Therapy 12/13/1952 - "[Myelophthisic anemia as terminal stage of polycythemia vera; protracted x-ray therapy followed by a myelosclerotic syndrome]."
3.	Splenectomy 01/01/2004 - "He developed leukoerythroblastic anemia three years after splenectomy. "